Medapp

Medapp Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Medapp (MDA.WA) as of Nov 21, 2026 is -94.39 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 255.84 % — a change of -136.89% (lower).

Cash Conversion

-94.39 %

YoY

-136.89%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Medapp is 2025 -94.39 % . Cash Conversion Rate (OCF/Net Income) of Medapp was 2024 255.84 % . It decreases by -136.89% lower compared to the previous year.

The Medapp Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
159.01 PLN
Jan 1, 2019
-589.73 PLN
Jan 1, 2020
-108.35 PLN
Jan 1, 2021
-10.60 PLN
Jan 1, 2022
939.57 PLN
Jan 1, 2023
42.40 PLN
Jan 1, 2024
255.84 PLN
Jan 1, 2025
-94.39 PLN
The Medapp Cash Conversion history
YEARCash ConversionYoY
-94.39 %-136.89%
255.84 %+503.32%
42.40 %-95.49%
939.57 %-8,964.67%
-10.60 %-90.22%
-108.35 %-81.63%
-589.73 %-470.88%
159.01 %+42.22%
111.81 %-35.54%
173.46 %-2,999.27%
-5.98 %-236.11%
4.40 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medapp Stock analysis

What does Medapp do? MedApp SA generates revenue through its mobile marketing solutions in the medical field, primarily via the Carna Life software application. Carna Life functions as a telemedicine platform enabling doctors and patients to communicate, with features including data upload and download for test results, offline data review, and graphical statistics. The company serves healthcare providers and patients seeking telemedicine services, focusing on the Polish market through its Krakow headquarters. Moonrock Enterprise SA controls MedApp SA, leveraging its software for medical communication solutions. The firm's revenue model centers on the Carna Life application, which provides telemedicine services by facilitating secure data exchange between doctors and patients. Patients use the app to upload test results, while doctors interpret them through the platform, supported by offline functionality and data visualization tools. This system targets medical professionals and patients in Poland, operating within the telemedicine sector without external partnerships or additional branded products. MedApp SA's business relies solely on the Carna Life telemedicine system, which offers both online and offline modes for data management. The application includes statistics, visualizations, and tables for interpreted medical data, serving as a communication channel between healthcare providers and patients. Controlled by Moonrock Enterprise SA, the company monetizes its software through direct sales to medical institutions and patient users in the Polish healthcare market. Medapp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medapp stock

Cash Conversion Rate (OCF/Net Income) of Medapp is -94.39 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Medapp changed from 255.84 % to -94.39 %, representing a -136.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Medapp since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Medapp with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Medapp

All Key Metrics — Medapp